Cargando…

COVID-19, Hyperglycemia, and New-Onset Diabetes

Certain chronic comorbidities, including diabetes, are highly prevalent in people with coronavirus disease 2019 (COVID-19) and are associated with an increased risk of severe COVID-19 and mortality. Mild glucose elevations are also common in COVID-19 patients and associated with worse outcomes even...

Descripción completa

Detalles Bibliográficos
Autores principales:	Khunti, Kamlesh, Del Prato, Stefano, Mathieu, Chantal, Kahn, Steven E., Gabbay, Robert A., Buse, John B.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	American Diabetes Association 2021
Materias:	Perspectives in Care
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8669536/ https://www.ncbi.nlm.nih.gov/pubmed/34625431 http://dx.doi.org/10.2337/dc21-1318

Ejemplares similares

Cardiovascular Disease and Type 2 Diabetes: Has the Dawn of a New Era Arrived?
por: Abdul-Ghani, Muhammad, et al.
Publicado: (2017)

Pathways to Quality Inpatient Management of Hyperglycemia and Diabetes: A Call to Action
por: Draznin, Boris, et al.
Publicado: (2013)

Metformin Benefits: Another Example for Alternative Energy Substrate Mechanism?
por: Giaccari, Andrea, et al.
Publicado: (2021)

Insulin Therapy in People With Type 2 Diabetes: Opportunities and Challenges?
por: Home, Philip, et al.
Publicado: (2014)

Personalized Management of Hyperglycemia in Type 2 Diabetes: Reflections from a Diabetes Care Editors’ Expert Forum
por: Raz, Itamar, et al.
Publicado: (2013)

Healthy lifestyle choices and microvascular complications: New insights into diabetes management
por: Chudasama, Yogini V., et al.
Publicado: (2023)

Adult-Onset Type 1 Diabetes: Current Understanding and Challenges
por: Leslie, R. David, et al.
Publicado: (2021)

New-Onset Diabetes in Covid-19
por: Rubino, Francesco, et al.
Publicado: (2020)

Lost opportunities to prevent early onset type 2 diabetes mellitus after a pregnancy complicated by gestational diabetes
por: Bernstein, Judith A, et al.
Publicado: (2016)

COVID-19 and diabetes: the contributions of hyperglycemia
por: Wang, Jing, et al.
Publicado: (2020)

Use of Metformin and Cardiovascular Effects of New Classes of Glucose-Lowering Agents: A Meta-analysis of Cardiovascular Outcome Trials in Type 2 Diabetes
por: Zaccardi, Francesco, et al.
Publicado: (2021)

COVID-19-INDUCED NEW ONSET DIABETES MELLITUS
por: KHALID, MADIHA, et al.
Publicado: (2021)

Innovations in Diabetes Care for a Better “New Normal” Beyond COVID-19
por: Agarwal, Shivani, et al.
Publicado: (2020)

Implementation of routine foot check in patients with diabetes on hemodialysis: associations with outcomes
por: Marn Pernat, Andreja, et al.
Publicado: (2016)

Patients' with type 2 diabetes willingness to pay for insulin therapy and clinical outcomes
por: Feher, Michael D, et al.
Publicado: (2016)

Beyond Metformin: Safety Considerations in the Decision-Making Process for Selecting a Second Medication for Type 2 Diabetes Management: Reflections From a Diabetes Care Editors’ Expert Forum
por: Cefalu, William T., et al.
Publicado: (2014)

Cystic Fibrosis–Related Diabetes Workshop: Research Priorities Spanning Disease Pathophysiology, Diagnosis, and Outcomes
por: Putman, Melissa S., et al.
Publicado: (2023)

Diabetic muscle infarction: a systematic review
por: Horton, William B, et al.
Publicado: (2015)

Declines in the Incidence of Diabetes in the U.S.—Real Progress or Artifact?
por: Selvin, Elizabeth, et al.
Publicado: (2017)

Relevance of positive cardiovascular outcome trial results in clinical practice: perspectives from the Academy for Cardiovascular Risk, Outcomes and Safety Studies in Type 2 Diabetes (ACROSS T2D)
por: Schernthaner, Guntram, et al.
Publicado: (2017)

NIDDK International Conference Report on Diabetes and Depression: Current Understanding and Future Directions
por: Holt, Richard I.G., et al.
Publicado: (2014)

The National Diabetes Education Program at 20 Years: Lessons Learned and Plans for the Future
por: Siminerio, Linda M., et al.
Publicado: (2018)

Discovering successful strategies for diabetic self-management: a qualitative comparative study
por: Weller, Susan C, et al.
Publicado: (2017)

Adherence of self-monitoring of blood glucose in persons with type 1 diabetes in Sweden
por: Moström, Peter, et al.
Publicado: (2017)

Management of hyperglycaemia in type 2 diabetes, 2022. A consensus report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD)
por: Davies, Melanie J., et al.
Publicado: (2022)

Addressing Therapeutic Inertia in 2020 and Beyond: A 3-Year Initiative of the American Diabetes Association
por: Gabbay, Robert A., et al.
Publicado: (2020)

Clinical Translation of Cardiovascular Outcome Trials in Type 2 Diabetes: Is There More or Is There Less Than Meets the Eye?
por: Ferrannini, Ele, et al.
Publicado: (2021)

The Evolution of Hemoglobin A(1c) Targets for Youth With Type 1 Diabetes: Rationale and Supporting Evidence
por: Redondo, Maria J., et al.
Publicado: (2021)

Medication usage, treatment intensification, and medical cost in patients with type 2 diabetes: a retrospective database study
por: Bonafede, Machaon, et al.
Publicado: (2016)

Innovative Designs and Logistical Considerations for Expedited Clinical Development of Combination Disease-Modifying Treatments for Type 1 Diabetes
por: Anderson, Randy L., et al.
Publicado: (2022)

Glucose Management Indicator (GMI): A New Term for Estimating A1C From Continuous Glucose Monitoring
por: Bergenstal, Richard M., et al.
Publicado: (2018)

COVID-19–Induced New-Onset Diabetes: Trends and Technologies
por: Metwally, Ahmed A., et al.
Publicado: (2021)

COVID-19-ASSOCIATED LEUKOENCEPHALOPATHY PRESENTING AS NEW ONSET REFRACTORY STATUS EPILEPTICUS
por: MARSHALL, TANYA, et al.
Publicado: (2021)

Hyperglycemia without diabetes and new-onset diabetes are both associated with poorer outcomes in COVID-19
por: Singh, Awadhesh Kumar, et al.
Publicado: (2020)

2019 Update to: Management of Hyperglycemia in Type 2 Diabetes, 2018. A Consensus Report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD)
por: Buse, John B., et al.
Publicado: (2020)

Update and Next Steps for Real-World Translation of Interventions for Type 2 Diabetes Prevention: Reflections From a Diabetes Care Editors’ Expert Forum
por: Cefalu, William T., et al.
Publicado: (2016)

FROM HOME TO ECMO: A CASE OF NEW-ONSET CARDIOMYOPATHY IN A PATIENT WITH POST-COVID-19 INFECTION
por: ADDERLEY, PATTON, et al.
Publicado: (2021)

Management of Hyperglycemia in Type 2 Diabetes, 2018. A Consensus Report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD)
por: Davies, Melanie J., et al.
Publicado: (2018)

Red and Processed Meats and Health Risks: How Strong Is the Evidence?
por: Qian, Frank, et al.
Publicado: (2020)

A Road Map for Peer Review of Real-World Evidence Studies on Safety and Effectiveness of Treatments
por: Winterstein, Almut G., et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_e19i7otvr4u8t9kedak6oai2bf